Home Therapies Liver Diseases

Liver Diseases

in Malaysia

What are Liver Diseases?

Liver diseases occur in two stages. In the first stage, a virus or toxin causes inflammation in the liver, which causes the immune system to initiate a protection response (M1) or a repair response (M2). The second stage occurs when the immune system mistakenly initiates the wrong response, causing programmed and unprogrammed cell death, elimination, and inflammation.

 

wjMSCs Treat Liver Diseases by

01Decreasing inflammation and toxicity in the liver, liver fibrosis, and cell death,
02Shifting immune response from M1 (protect) to M2 (repair),
03Promoting liver recovery,
04Transforming into lost and damaged cells, and
05Encouraging existing cells to self-repair.

Interested?

Talk to Your Primary Doctor First

They're pros who can give you personalized advice and recommend the latest treatment options that suit your unique condition.

One Size Does Not Fit All

Our doctors decide how many wjMSCs, the transfusion method, and the rounds of treatment that you need based on your medical records. So, be sure to send them to your patient liaison.

Research Findings

Multiple universities and institutions from across the globe have examined the efficacy of using wjMSCs to treat liver diseases and reported promising outcomes.

Zhejiang University, China
Significantly improved the model of end-stage liver disease score; albumin, alanine aminotransferase, and total bilirubin levels; and prothrombin time of liver disease patients.
Beijing 302 Hospital, China
Significantly increased the albumin levels of decompensated cirrhosis patients, with a marked reduction in ascites.
Tehran University, Iran
Improved the model of end-stage liver disease score and quality of life of decompensated liver cirrhosis patients.
University of Malaya Medical Centre, Malaysia
Improved the serum total bilirubin and serum albumin levels of decompensated alcoholic liver cirrhosis patients, with reduced dependence on diuretics for ascites management.
Imperial College London, United Kingdom
Improved the serum bilirubin levels of chronic liver disease patients, with computed tomography and serum α-foetoprotein-supported absence of focal lesions.
Owaisi Hospital and Research Center, India
Improved the serum albumin, bilirubin, and alanine transaminase levels of liver insufficiency patients.
The Catholic University of Korea, South Korea
Improved the serum albumin levels, liver stiffness, liver volume, subjective health, and quality of life of liver failure patients.
Beijing 302 Hospital, China
Alleviated fatigue and pruritus; and significantly decreased the serum alkaline phosphatase and γ-glutamyltransferase levels of primary biliary cirrhosis patients with incomplete responses to ursodeoxycholic acid (UDCA) treatment.
Cairo University, Egypt
Partially improved the liver function test results; elevated the prothrombin concentration and serum albumin levels, and decreased the elevated bilirubin and model of end-stage liver disease score of chronic hepatitis C liver failure patients.
Cairo University, Egypt
Normalised the liver enzymes and improved the liver synthetic function, serum albumin, prothrombin concentration, and alanine transaminase levels of end-stage liver disease patients.
The Third Affiliated Hospital of Sun Yat-sen University, China
Improved the albumin, total bilirubin, prothrombin time, and model for end-stage liver disease score of chronic hepatitis B liver failure patients.
Hallym University College of Medicine, South Korea
Improved histologic fibrosis and liver function in patients with alcoholic cirrhosis.
Wenzhou Medical University, China
Improved the liver function of patients with hepatitis B liver cirrhosis patients.
Al-Azhar University, Egypt
Improved the ascites, lower limb oedema, fatigue, serum albumin levels, and model for end-stage liver disease score of chronic hepatitis C liver failure patients.

What Makes Us Different?

Premium grade passage 2 wjMSCs

Our premium grade passage 2 wjMSCs are ethically derived from the umbilical cord tissues of healthy human babies that have been delivered after 37 weeks of gestation.

cGMP & ISO 9001 certified

Our laboratory is not only current goods & manufacturing practices (cGMP) certified, but ISO 9001 certified as well, both of which are internationally recognised standards for quality management systems (QMS).

Crafters of high-quality products

Our bio-safety level (BSL) 2 laboratory adheres to international standard operating procedures to ensure cleanliness and sterility as well as the safety of the environment.

Patient journey for international patients

Enquire now

The Patient Liaison that you are assigned will require your medical information. To streamline the process, either send your existing medical records to your Patient Liaison or get a medical test done in your country of residence and send it to your Patient Liaison.

Planning your treatment

Your Patient Liaison will send your medical reports to our doctors, who will tailor a personalised treatment plan for you or request that you get more medical tests done in your country of residence and send it to your Patient Liaison.

Ready to begin?

Once you've agreed to the treatment plan, let your Patient Liaison know when you'd like to start your treatment. They'll coordinate with our doctors and book a treatment slot for you.

Secure your spot

Let your Patient Liaison know how many people will be accompanying you to Malaysia and if you have any special requirements, such as ambulance or wheelchair assistance. You'll need to pay a deposit depending on the duration of your treatment, number of travellers, and special needs so that your Patient Liaison may make appropriate hotel bookings and transport arrangements.

Visas made easy

Visit the Immigration Department of Malaysia's website to check if you need a visa to enter the country. You may apply for an electronic visa (eVisa) here. Let your Patient Liaison know if you require an Invitation Letter and they'll send you one.

Book your flight tickets

When booking your flight tickets, it's recommended to arrive two days before your treatment date and to depart the day after your treatment ends.

Malaysia Digital Arrival Card (MDAC) registration

Two days before your arrival in Malaysia, go to this link to register yourself and all other travellers.

Arrival & airport transfer

Your Patient Liaison will organise your airport transfer to the hotel and send you your driver's contact details via email. Log in to "Airport WiFi" to check your email once you've landed at KLIA and contact your driver.

Check-in & pay for treatment

Your Patient Liaison will meet you at the hotel and help you check-in. You will be required to pay the remainder of your treatment fee in order for the laboratory to begin preparing the products for your treatment, which will be two days later. We accept cash, online funds transfers, PayPal, and credit / debit cards (Visa, MasterCard, American Express, JCB, Union Pay).

Let the healing begin

Your Patient Liaison will arrange transportation to and from the treatment facility on the treatment date and walk you through the registration and discharge processes.

Show more

Hear from Our Patients

More than 200 people have chosen Cyrona, why not you?
Learn more about our

Liver Diseases

Therapy Programme
Captcha

Download our complimentary eBook!